[摘要] 动脉粥样硬化(AS)是心脑血管事件的共同病理基础。胆固醇逆向转运(RCT)在AS进程中发挥关键作用。前蛋白转化酶枯草溶菌素9(PCSK9)、分化抗原36(CD36)与RCT密切相关。结合补肾中药复方干预治疗AS的前期研究，本文拟从PCSK9调控CD36、介导RCT角度探讨补肾中药复方防治AS的研究策略。

    [关键词] 动脉粥样硬化;胆固醇逆向转运;前蛋白转化酶枯草溶菌素9;分化抗原36;补肾中药复方

    [中图分类号] R543 [文献标识码] A [文章编号] 1673-7210(2019)03(a)-0116-04

    [Abstract] Atherosclerosis (AS) is the common pathological basis of cardiovascular and cerebrovascular events. Reverse cholesterol transport (RCT) plays an important role in the progress of AS. Proprotein convertase subtilisin/kexin type 9 (PCSK9) and cluster of differentiation 36 (CD36) are closely related to RCT. Combined with the preliminary research that compound Chinese medicine for reinforcing kidney can intervene AS ......